Search results for "microRNA."

showing 10 items of 574 documents

RIP-Chip analysis supports different roles for AGO2 and GW182 proteins in recruiting and processing microRNA targets.

2019

Background MicroRNAs (miRNAs) are small non-coding RNA molecules mediating the translational repression and degradation of target mRNAs in the cell. Mature miRNAs are used as a template by the RNA-induced silencing complex (RISC) to recognize the complementary mRNAs to be regulated. To discern further RISC functions, we analyzed the activities of two RISC proteins, AGO2 and GW182, in the MCF-7 human breast cancer cell line. Methods We performed three RIP-Chip experiments using either anti-AGO2 or anti-GW182 antibodies and compiled a data set made up of the miRNA and mRNA expression profiles of three samples for each experiment. Specifically, we analyzed the input sample, the immunoprecipita…

Chromatin ImmunoprecipitationSupport Vector MachineRIP-Chip data analysisMiRNA bindingComputational biologyBiologylcsh:Computer applications to medicine. Medical informaticsBiochemistryAutoantigens03 medical and health sciencesOpen Reading Frames0302 clinical medicineStructural BiologymicroRNARIP-Chip data analysiCoding regionGene silencingHumansRNA MessengerMolecular BiologyGenelcsh:QH301-705.5030304 developmental biology0303 health sciencesBinding SitesApplied MathematicsGene Expression ProfilingResearchRNARNA-Binding ProteinsmicroRNA target predictionRISC proteins AGO2 and GW182Computer Science ApplicationsSettore BIO/18 - GeneticaMicroRNAslcsh:Biology (General)Gene Expression Regulation030220 oncology & carcinogenesismicroRNA regulatory activityArgonaute ProteinsMCF-7 Cellslcsh:R858-859.7DNA microarrayRIP-ChipBMC bioinformatics
researchProduct

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

2018

AbstractIn this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of non-invasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743 miRNAs were screened in two independent cohorts of 131 and 54 patients. Evaluation of serum miRNA variance in a model testing for tumor stage, MYCN status, age at diagnosis and overall survival, revealed tumor stage as the most significant factor impacting miRNA abundance in neuroblastoma serum. Differential expression analysis between patients with metastatic and localized disease revealed 9 miRNAs strongly associated with metastatic stage 4 …

Circulating MicroRNADifferential expression analysisbusiness.industryLocalized diseaseNeuroblastomamicroRNATumor stageCancer researchMedicineDiseaseStage (cooking)businessmedicine.disease
researchProduct

Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging.

2019

Circulating mirnasSkin Neoplasmsbusiness.industrySequence Analysis RNADermatologyInfectious DiseasesPotential biomarkersExpression analysisCutaneous melanomaCancer researchBiomarkers TumorMedicineHumansCirculating MicroRNAbusinessMelanomaNeoplasm StagingJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct

Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women

2014

INTRODUCTION: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast cancer surgery and evaluate whether these alterations were also observed in an independent data set.METHODS: Global miRNA analysis was performed on prospectively collected serum samples from 24 post-menopausal women with estrogen receptor-positive early-stage breast cancer before surgery and 3 weeks after tumor resection using global LNA-based quantitative real-time PCR (qPCR).RESULTS: Numbers of specific miRNAs detected in the samples ranged fro…

Circulating mirnaslcsh:MedicineEstrogen receptorBreast NeoplasmsBioinformaticsBiochemistryBreast cancerSurgical oncologymicroRNABreast TumorsBreast CancermedicineMedicine and Health SciencesBiomarkers TumorHumansPostoperative PeriodStage (cooking)lcsh:Scienceskin and connective tissue diseasesAgedNeoplasm StagingAged 80 and overMultidisciplinarybusiness.industrylcsh:RCarcinoma Ductal BreastCancerBiology and Life SciencesCancers and NeoplasmsMiddle Agedmedicine.diseasePostmenopauseCirculating MicroRNAMicroRNAsOncologyReceptors Estrogenlcsh:QFemalebusinessBiomarkersResearch ArticlePLoS ONE
researchProduct

PO-344 miR-302b as adjuvant therapeutic tool to improve chemotherapy efficacy in human triple negative breast cancer

2018

Introduction MiRNAs are a class of non-coding regulatory RNAs playing key roles in different biological processes including cancer. Triple-negative breast cancer (TNBC) accounts for 15%–20% of all breast cancer cases, with the worst outcome of all subtypes. For TNBC, still lacking targeted therapies, the only therapeutic option is chemotherapy. MiRNAs can modulate chemotherapy response by affecting DNA repair, cell cycle progression, apoptosis and also tumour microenvironment. Macrophages constitute a major component of the immune microenvironment of cancer and pro-tumour M2 macrophages have been associated with response to chemotherapeutic treatments. Here, we investigated the potential of…

CisplatinCancer Researchbusiness.industryCancermedicine.diseaseBreast cancerOncologymicroRNACancer researchGene silencingMedicinebusinessITGA6Triple-negative breast cancermedicine.drugIRF4ESMO Open
researchProduct

Assessing the impact of copy number variants on miRNA genes in autism by Monte Carlo simulation.

2014

Autism Spectrum Disorders (ASDs) are childhood neurodevelopmental disorders with complex genetic origins. Previous studies have investigated the role of de novo Copy Number Variants (CNVs) and microRNAs as important but distinct etiological factors in ASD. We developed a novel computational procedure to assess the potential pathogenic role of microRNA genes overlapping de novo CNVs in ASD patients. Here we show that for chromosomes # 1, 2 and 22 the actual number of miRNA loci affected by de novo CNVs in patients was found significantly higher than that estimated by Monte Carlo simulation of random CNV events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only …

Clinical PathologyDNA Copy Number Variationsendocrine system diseasesChromosomes Human Pair 22ScienceGene regulatory networkGenomicsDevelopmental and Pediatric NeurologyBiologyPathology and Laboratory MedicinePediatricsGenomeMolecular GeneticsmiRNA Genes Monte Carlo Simulation AutismDiagnostic Medicinemental disordersGeneticsMedicine and Health SciencesmedicineHumansComputer SimulationGene Regulatory NetworksCopy-number variationAutistic DisorderGeneGeneticsMultidisciplinaryGenome HumanQRBiology and Life SciencesComputational BiologyGenomicsGenome Analysismedicine.diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)MicroRNAsNeurologyChromosomes Human Pair 1Genetic LociAutism spectrum disorderChromosomes Human Pair 2AutismMedicineStructural GenomicsHuman genomeMonte Carlo MethodResearch ArticlePLoS ONE
researchProduct

The Potential Role of miRNAs in Cognitive Frailty.

2021

Frailty is an aging related condition, which has been defined as a state of enhanced vulnerability to stressors, leading to a limited capacity to meet homeostatic demands. Cognitive impairment is also frequent in older people, often accompanying frailty. Age is the main independent risk factor for both frailty and cognitive impairment, and compelling evidence suggests that similar age-associated mechanisms could underlie both clinical conditions. Accordingly, it has been suggested that frailty and cognitive impairment share common pathways, and some authors proposed “cognitive frailty” as a single complex phenotype. Nevertheless, so far, no clear common underlying pathways have been discove…

Cognitive frailtyAgingbiomarkers cognitive frailty cognitive impairment frailty MCI (mild cognitive impairment) miRNA–microRNACognitive NeuroscienceVulnerabilitycognitive frailtyNeurosciences. Biological psychiatry. NeuropsychiatryReviewfrailtyMCI (mild cognitive impairment)MCI (mild cognitive impairment); biomarkers; cognitive frailty; cognitive impairment; frailty; miRNA–microRNAmicroRNAMedicinePathologicalcognitive impairmentbusiness.industryStressorbiomarkers; cognitive frailty; cognitive impairment; frailty; MCI (mild cognitive impairment); miRNA–microRNAbiomarkersCognitionPhenotypemiRNA–microRNAPotential biomarkersbiomarkerbusinessNeuroscienceRC321-571NeuroscienceFrontiers in aging neuroscience
researchProduct

Upregulated MicroRNAs 342 and 15a Mediate Host-Pathogen Interaction in Pneumococcal Community-Acquired Pneumonia

2020

Community-acquired pneumoniaDownregulation and upregulationHost–pathogen interactionmicroRNAmedicineBiologymedicine.diseaseMicrobiologyB28. HOST AND MICROBIAL CLINICAL STUDIES IN LUNG INFECTIONS AND LUNG DISEASES
researchProduct

MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy

2019

Myotonic dystrophy involves two types of chronically debilitating rare neuromuscular diseases: type 1 (DM1) and type 2 (DM2). Both share similarities in molecular cause, clinical signs, and symptoms with DM2 patients usually displaying milder phenotypes. It is well documented that key clinical symptoms in DM are associated with a strong mis-regulation of RNA metabolism observed in patient’s cells. This mis-regulation is triggered by two leading DM-linked events: the sequestration of Muscleblind-like proteins (MBNL) and the mis-regulation of the CUGBP RNA-Binding Protein Elav-Like Family Member 1 (CELF1) that cause significant alterations to their important functions in RNA processing. It ha…

Context (language use)miRNA-based drugReviewBioinformaticsMyotonic dystrophyCatalysislcsh:ChemistryInorganic ChemistryMBNL proteinsCELF1microRNADrug DiscoveryMedicineAnimalsHumansPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyCELF1 ProteinRna processingmyotonic dystrophymicroRNAbusiness.industryOrganic ChemistryAlternative splicingmiRNA-targeting drugRNA-Binding ProteinsGeneral MedicineGenetic Therapymedicine.diseasePhenotypeComputer Science ApplicationsAlternative SplicingMicroRNAslcsh:Biology (General)lcsh:QD1-999Drug developmentGene Expression Regulationantisense oligonucleotidesbusinessFunction (biology)International Journal of Molecular Sciences
researchProduct

Dynamic architecture and regulatory implications of the miRNA network underlying the response to stress in melon

2019

miRNAs are small RNAs that regulate mRNAs at both transcriptional and posttranscriptional level. In plants, miRNAs are involved in the regulation of different processes including development and stress-response. Elucidating how stress-responsive miRNAs are regulated is key to understand the global response to stress but also to develop efficient biotechnological tools that could help to cope with stress. Here, we describe a computational approach based on sRNA sequencing, transcript quantification and degradome data to analyse the accumulation, function and structural organization of melon miRNAs reactivated under seven biotic and abiotic stress conditions at two and four days post-treatmen…

Crops AgriculturalMelonTranscript quantificationPeriod (gene)Computational biologyBiologyRegulation of the stress response in crops03 medical and health sciences0302 clinical medicineGene Expression Regulation PlantStress PhysiologicalStress (linguistics)microRNAGene Regulatory NetworksGene SilencingMolecular Biology030304 developmental biology0303 health sciencesStructural organizationAbiotic stressCell BiologyMicroRNAsCucurbitaceaeRNA silencingPhenotypemiRNA networks030220 oncology & carcinogenesissRNAs analisysRNA InterferenceRNA silencingFunction (biology)Research PaperRNA Biology
researchProduct